EPSTEIN-BARR VIRUS

Clinical trials for EPSTEIN-BARR VIRUS explained in plain language.

Never miss a new study

Get alerted when new EPSTEIN-BARR VIRUS trials appear

Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

First human test for Long-Awaited EBV vaccine begins

⭐️ VACCINE ⭐️
This is an early-stage study to test the safety and immune response of a new mRNA vaccine, mRNA-1189, designed to prevent Epstein-Barr virus (EBV) infection. It will enroll 120 healthy adults aged 18-30 to receive the vaccine either as a shot in the skin or muscle. The main goals…

Matched conditions: EPSTEIN-BARR VIRUS

Status: NOT_YET_RECRUITING • Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 19, 2026 14:56 UTC

EPSTEIN-BARR VIRUS

Get alerted when new EPSTEIN-BARR VIRUS trials appear

First human test for Long-Awaited EBV vaccine begins